20-10650275-TG-TGG
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000214.3(JAG1):c.1205dupC(p.Gln403ThrfsTer13) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000214.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- Alagille syndrome due to a JAG1 point mutationInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- Charcot-Marie-Tooth disease, axonal, Type 2HHInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- tetralogy of fallotInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| JAG1 | NM_000214.3 | c.1205dupC | p.Gln403ThrfsTer13 | frameshift_variant | Exon 9 of 26 | ENST00000254958.10 | NP_000205.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| JAG1 | ENST00000254958.10 | c.1205dupC | p.Gln403ThrfsTer13 | frameshift_variant | Exon 9 of 26 | 1 | NM_000214.3 | ENSP00000254958.4 | ||
| JAG1 | ENST00000423891.6 | n.1071dupC | non_coding_transcript_exon_variant | Exon 7 of 25 | 2 | |||||
| JAG1 | ENST00000617965.2 | n.1794dupC | non_coding_transcript_exon_variant | Exon 3 of 17 | 5 | |||||
| JAG1 | ENST00000622545.1 | n.-20dupC | upstream_gene_variant | 5 | ENSP00000484139.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Alagille syndrome due to a JAG1 point mutation Pathogenic:3
This sequence change creates a premature translational stop signal (p.Gln403Thrfs*13) in the JAG1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JAG1 are known to be pathogenic (PMID: 11180599). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Alagille syndrome (PMID: 9585603). ClinVar contains an entry for this variant (Variation ID: 213558). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
The c.1205dupC mutation in the JAG1 gene has been reported previously in association with Alagille syndrome using different nomenclature (Krantz, et al., 1998) . The duplication causes a frameshift starting with codon Glycine 403, changes this amino acid to a Threonine residue and creates a premature Stop codon at position 13 of the new reading frame, denoted p.Gln403ThrfsX13. This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay This variant was found in JAG1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at